Glial Changes and Evidence for Apoptosis in the Brain of Cats Infected by Cytauxzoon felis

2017 ◽  
Vol 156 (2-3) ◽  
pp. 147-151 ◽  
Author(s):  
L.L. Clarke ◽  
P.M. Krimer ◽  
D.R. Rissi
Author(s):  
James A. Goodrich ◽  
Jung H. Kim ◽  
Robert Situ ◽  
Wesley Taylor ◽  
Ted Westmoreland ◽  
...  

2020 ◽  
Author(s):  
Ana Catarina Rodrigues Neves ◽  
Rafael Carecho ◽  
Sónia C. Correia ◽  
Cristina Carvalho ◽  
Elisa J. Campos ◽  
...  

Abstract Background: The concept 'the retina as a window to the brain' in Alzheimer´s disease (AD) has been explored in recent years since patients sometimes present visual alterations before the first symptoms of dementia. The retina is an extension of the brain and can be assessed by non-invasive methods. However, assessing the retina for AD diagnosis is still a matter of debate. Using the triple transgenic mouse model of AD (3xTg-AD), this study was undertaken to investigate whether the retina and brain undergo similar molecular and cellular changes during the early stages of AD pathology, and if the retina could anticipate the pathological alterations occurring in the brain. Methods: We used the 3xTg-AD and wild-type mice (C57BL6/129S), at 4 and 8 months of age, and assessed several parameters in the retina and brain (hippocampus and cortex): amyloid-beta (Aβ) and hyperphosphorylated tau (p-tau) levels, barrier permeability, cell death, neurotransmitter levels and glial changes. Results: We detected increased Aβ levels in the hippocampus and cortex and increased p-tau in the hippocampus, retina and cortex of 3xTg-AD mice. The brain and retinal barriers were unaffected. At 4 months, the content of some synaptic proteins increased in the brain but not in the retina. No cell death, including retinal ganglion cells loss, was detected in 3xTg-AD mice. Overall, no changes were observed in glutamate and GABA levels in all regions. There was an increase in astrogliosis in the hippocampus at 4 months and a decrease in the retina at 8 months. No changes were detected in Müller cells reactivity. Furthermore, we did not find changes in the number of microglia in 3xTg-AD mice, but we detected a different profile in microglia branching in the hippocampus and retina, at 4 months, where the number and length of the processes increased in the hippocampus and decreased in the retina. Conclusions: At the early stages of pathology, the retina, hippocampus and cortex of 3xTg-AD are not significantly affected, but already present some molecular and cellular alterations. The retina did not mirror the changes detected in the brain in this animal model of familial AD, and these observations should be taking into account when using the retina as a potential diagnostic tool for AD.


1990 ◽  
Vol 18 (3) ◽  
pp. 287-291 ◽  
Author(s):  
Kazuo YAMADA ◽  
Toru HAYAKAWA ◽  
Akira KINOSHITA ◽  
Eiji KOHMURA ◽  
Junji TAGUCHI ◽  
...  

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Luisa Seguella ◽  
Mirella Pesce ◽  
Riccardo Capuano ◽  
Fabrizio Casano ◽  
Marcella Pesce ◽  
...  

Abstract Background Mood and metabolic disorders are interrelated and may share common pathological processes. Autonomic neurons link the brain with the gastrointestinal tract and constitute a likely pathway for peripheral metabolic challenges to affect behaviors controlled by the brain. The activities of neurons along these pathways are regulated by glia, which exhibit phenotypic shifts in response to changes in their microenvironment. How glial changes might contribute to the behavioral effects of consuming a high-fat diet (HFD) is uncertain. Here, we tested the hypothesis that anxiogenic and depressive-like behaviors driven by consuming a HFD involve compromised duodenal barrier integrity and subsequent phenotypic changes to glia and neurons along the gut-brain axis. Methods C57Bl/6 male mice were exposed to a standard diet or HFD for 20 weeks. Bodyweight was monitored weekly and correlated with mucosa histological damage and duodenal expression of tight junction proteins ZO-1 and occludin at 0, 6, and 20 weeks. The expression of GFAP, TLR-4, BDNF, and DCX were investigated in duodenal myenteric plexus, nodose ganglia, and dentate gyrus of the hippocampus at the same time points. Dendritic spine number was measured in cultured neurons isolated from duodenal myenteric plexuses and hippocampi at weeks 0, 6, and 20. Depressive and anxiety behaviors were also assessed by tail suspension, forced swimming, and open field tests. Results HFD mice exhibited duodenal mucosa damage with marked infiltration of immune cells and decreased expression of ZO-1 and occludin that coincided with increasing body weight. Glial expression of GFAP and TLR4 increased in parallel in the duodenal myenteric plexuses, nodose ganglia, and hippocampus in a time-dependent manner. Glial changes were associated with a progressive decrease in BDNF, and DCX expression, fewer neuronal dendritic spines, and anxiogenic/depressive symptoms in HFD-treated mice. Fluorocitrate (FC), a glial metabolic poison, abolished these effects both in the enteric and central nervous systems and prevented behavioral alterations at week 20. Conclusions HFD impairs duodenal barrier integrity and produces behavioral changes consistent with depressive and anxiety phenotypes. HFD-driven changes in both peripheral and central nervous systems are glial-dependent, suggesting a potential glial role in the alteration of the gut-brain signaling that occurs during metabolic disorders and psychiatric co-morbidity.


Sign in / Sign up

Export Citation Format

Share Document